Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Chenguang Tianrun Pharmaceutical is a specialized manufacturer of plant-derived active pharmaceutical ingredients (APIs) and a key subsidiary of the Chenguang Biotech Group. The company focuses on the industrial-scale extraction and purification of botanical compounds, most notably silymarin and ginkgo biloba extracts, for use in pharmaceutical and health supplement applications. Operating out of Handan, Hebei, the firm utilizes advanced extraction technologies and maintains rigorous GMP-compliant production standards to serve international markets. Their business model integrates the parent company's raw material sourcing strengths with high-tech processing to deliver high-purity natural products. Chenguang Tianrun plays a significant role in the global supply chain for liver-protective and cardiovascular-supportive botanical medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北晨光天润制药.